US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.85

+0.34500.90%

Volume:1.03M

Turnover:39.78M

Market Cap:5.22B

PE:-11.15

High:40.07

Open:38.50

Low:38.10

Close:38.50

52wk High:49.70

52wk Low:8.70

Shares:134.37M

Float Shares:131.11M

Volume Ratio:0.58

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.68

PE(LYR):-18.86

Loading ...

Overview Company News Filings

Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54

MT Newswires Live

Definium Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)

Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs

Definium Net Loss More than Doubled to $159 Million in Q2 FY26

Definium Therapeutics Inc Q2 Net Income USD -158.986 Million

Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate

Benzinga Earnings

Definium Therapeutics, Inc. options imply 14.8% move in share price post-earnings

Definium Therapeutics Sets August 6 Date to Report Q2 2026 Results

Definium Therapeutics Issues Equity Inducement Grants to New Hires

Definium Therapeutics Launches GAD Education Platform Wired for Worry

Definium Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview

Definium Therapeutics Issues Inducement Options for 115,600 Shares to Six New Hires

Press Release: Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Definium Therapeutics to Webcast Q2 Financial Results Update

Definium Therapeutics, Inc. options imply 11.0% move in share price post-earnings

Definium Therapeutics Initiated at Overweight by Wells Fargo

Definium Therapeutics initiated with an Overweight at Wells Fargo

Definium Therapeutics Price Target Raised to $73.00/share from $48.00 by Piper Sandler

Definium Therapeutics price target raised to $73 from $48 at Piper Sandler

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/DFTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.845,"timestamp":1788378569536,"preClose":38.5,"halted":0,"volume":1027714,"delay":0,"changeRate":0.008961038961038932,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":0.345,"latestTime":"09-02 15:49:31 EDT","open":38.5,"high":40.065,"low":38.1,"amount":39776796.813099995,"amplitude":0.051039,"askPrice":38.88,"askSize":90,"bidPrice":38.8,"bidSize":210,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":38.5,"preHourTrading":{"tag":"盘前","latestPrice":38.3,"preClose":38.5,"latestTime":"09:27 EDT","volume":6540,"amount":246819.8616,"timestamp":1788355679328,"change":-0.2,"changeRate":-0.005195,"amplitude":0.037922},"postHourTrading":{"tag":"盘后","latestPrice":38.6,"preClose":38.5,"latestTime":"19:58 EDT","volume":24860,"amount":958344.1953,"timestamp":1788307117321,"change":0.1,"changeRate":0.002597,"amplitude":0.01974},"volumeRatio":0.580474,"impliedVol":1.0367,"impliedVolPercentile":0.6266},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.580474,"shares":134366950,"dividePrice":0,"high":40.065,"amplitude":0.051039,"preClose":38.5,"low":38.1,"week52Low":8.7,"pbRate":"5.68","week52High":49.7,"institutionHeld":0,"latestPrice":38.845,"committee":0.4,"eps":-3.482311,"divideRate":0,"volume":1027714,"delay":0,"ttmEps":-3.482311,"open":38.5,"prevYearClose":13.39,"prevWeekClose":40.98,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":43.77,"twentyDayClose":44.39,"sixtyDayClose":23.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-01","current":-11.055876,"percent":0.307692,"low":-27.074722,"twenty":-17.384314,"median":-11.106728,"eighty":-9.894411,"high":-8.802064,"avg":-13.907193,"sd":5.5199,"marketCap":5337055254},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-01","current":-15.085589,"twenty":-17.384314,"median":-11.106728,"eighty":-9.894411,"marketCap":5337055254}],"updateTime":1788341670804},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657966523","title":"Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2657966523","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657966523?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:09","pubTimestamp":1786050595,"startTime":"0","endTime":"0","summary":"Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663039","title":"Definium Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663039","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663039?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050110,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryDefinium Therapeutics IncDFTX.OQreported a quarterly adjusted loss of $1.44 per share for the quarter ended Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502456","title":"Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502456?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047479,"startTime":"0","endTime":"0","summary":"of June 30, 2026, Definium Therapeutics (DFTX) had cash, cash equivalents and investments of approximately $1.1 billion compared to $411.6 million ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-reports-q2-eps-1-44-consensus-53c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-reports-q2-eps-1-44-consensus-53c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650957","title":"Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650957","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650957?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047436,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 net loss widens on higher warrant costsOverviewUS biopharma firm's Q2 net loss widens, driven by higher warrant liabilities and expensesCompany raised $805 mln in public offer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007","VTVT","PRAX","LU0109394709.USD","BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBRN","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0889565916.HKD","LU0320765992.SGD","DTIL","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465751","title":"Definium Net Loss More than Doubled to $159 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465751","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465751?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046756,"startTime":"0","endTime":"0","summary":"Definium net loss more than doubled to $159 million in Q2 FY26Definium Therapeutics posted a Q2 net loss of $159 million versus $42.7 million a year earlier, driven by an $86.2 million non-cash warran","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3WWV91:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652717","title":"Definium Therapeutics Inc Q2 Net Income USD -158.986 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652717","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652717?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046521,"startTime":"0","endTime":"0","summary":"BRIEF-Definium Therapeutics Inc Q2 Net Income USD -158.986 MillionAug 06 (Reuters) - Definium Therapeutics Inc Q2 income from operations USD -75.077 million.Q2 EPS USD -1.44Q2 operating expenses USD 75.077 millionQ2 basic EPS USD -1.44","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLX34K6CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266652","title":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266652","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266652?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046496,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/DFTX","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654259","title":"Definium Therapeutics, Inc. options imply 14.8% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657654259?lang=en_us&edition=fundamental","pubTime":"2026-08-07 03:20","pubTimestamp":1786044030,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Definium Therapeutics (DFTX), Inc. is 6.7x normal with calls leading puts 84:1. Implied volatility suggests the mark...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-14-8-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-14-8-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGFPF","DFTX","RGLO","VOTE","GXDW","PMDE","JOYT","DECU","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656759","title":"Definium Therapeutics Sets August 6 Date to Report Q2 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656759?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:00","pubTimestamp":1786035616,"startTime":"0","endTime":"0","summary":"An announcement from Definium Therapeutics ( ($DFTX) ) is now available. Definium Therapeutics, Inc. said it will report its second-quarter 2026 fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-sets-august-6-date-to-report-q2-2026-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-sets-august-6-date-to-report-q2-2026-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655014","title":"Definium Therapeutics Issues Equity Inducement Grants to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655014?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:14","pubTimestamp":1786032850,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has provided an announcement. Definium Therapeutics has granted stock options to eight newly hired non-executive ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-equity-inducement-grants-to-new-hires?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-equity-inducement-grants-to-new-hires?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VMRK","EQR","DFTX","BK4585","BK4215","BK4007","REZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655099","title":"Definium Therapeutics Launches GAD Education Platform Wired for Worry","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655099?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:13","pubTimestamp":1786032781,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has provided an announcement. Definium Therapeutics has launched Wired for Worry, a disease education platform fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-launches-gad-education-platform-wired-for-worry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-launches-gad-education-platform-wired-for-worry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657871598","title":"Definium Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657871598","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657871598?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:21","pubTimestamp":1785882068,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Inc <DFTX.OQ> expected to post a loss of55cents a share - Earnings PreviewDefinium Therapeutics IncDFTX.OQDFTX.Ois expected to  show no change in quarterly revenue when it report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4413FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309732","title":"Definium Therapeutics Issues Inducement Options for 115,600 Shares to Six New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309732?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787271,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement options for 115,600 shares to six new hiresDefinium Therapeutics issued inducement stock options covering 115,600 common shares to six newly hired non-executive","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9lB9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655389313","title":"Press Release: Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655389313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655389313?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:50","pubTimestamp":1785444600,"startTime":"0","endTime":"0","summary":"NEW YORK--(BUSINESS WIRE)--July 30, 2026--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address un","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383505","title":"Definium Therapeutics to Webcast Q2 Financial Results Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383505","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383505?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:02","pubTimestamp":1785441735,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to webcast Q2 financial results updateDefinium Therapeutics schedules a webcast for Aug. 6, 2026 at 4:30 p.m. EDT to report Q2 2026 financial results.Webcast registration availab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLKyMBn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655218388","title":"Definium Therapeutics, Inc. options imply 11.0% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2655218388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655218388?lang=en_us&edition=fundamental","pubTime":"2026-07-31 03:30","pubTimestamp":1785439828,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Definium Therapeutics (DFTX), Inc. is normal with calls leading puts 9:4. Implied volatility suggests the market is ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-11-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-11-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FEBU","GXDW","VOTE","VGFPF","PMDE","RGLO","JOYT","DECU","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654048530","title":"Definium Therapeutics Initiated at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654048530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654048530?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:54","pubTimestamp":1785156840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJuly 27, 2026 08:54 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016935","title":"Definium Therapeutics initiated with an Overweight at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016935?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:25","pubTimestamp":1785144321,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett initiated coverage of Definium Therapeutics (DFTX) with an Overweight rating and $68 price target The firm bel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-an-overweight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-initiated-with-an-overweight-at-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653817035","title":"Definium Therapeutics Price Target Raised to $73.00/share from $48.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2653817035","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653817035?lang=en_us&edition=fundamental","pubTime":"2026-07-24 23:11","pubTimestamp":1784905860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings(END) Dow Jones NewswiresJuly 24, 2026 11:11 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653341089","title":"Definium Therapeutics price target raised to $73 from $48 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2653341089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653341089?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:55","pubTimestamp":1784890521,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Definium Therapeutics (DFTX) to $73 from $48 and keeps an Overweight rating on the shares. The firm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-73-from-48-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-73-from-48-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}